Skip to content
value.today
Glaukos Corp. logo

Glaukos Corp.

Formerly Glayco Corporation, TransDx, Inc.

Total raised
$76 M
5 rounds on record
Latest round
$30 M
Jan 2013
First round on record
Sep 2010
Today
Went public
See the company page

Glaukos Corp. is listed today as Glaukos Corporation: market value, financials and filings are on its company page.

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Glaukos Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2013$30 MNo. 5$10 to $50 million

Glaukos Corp.: Raise no. 5, Jan 2013

Investors in this round

20 investors had bought by the notice of Jan 25, 2013: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Glaukos Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Olav B. Bergheim · Executive Officer, Director
  • Richard W. Harrison · Executive Officer
  • Thomas W. Burns · Executive Officer, Director
  • Daniel K. Turner · Director
  • Gilbert H. Kliman · Director
  • Jonathan T. Silverstein · Director
  • Paul S. Madera · Director
  • Robert J. More · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard L. Harrison, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 25, 2013. Read the notice at the SEC.

equitySEC
Oct 2012$6 MNo. 4$2 to $10 million

Glaukos Corp.: Raise no. 4, Oct 2012

Investors in this round

11 investors had bought by the notice of Oct 3, 2012: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Glaukos Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Olav B. Bergheim · Executive Officer, Director
  • Richard W. Harrison · Executive Officer
  • Thomas W. Burns · Executive Officer, Director
  • Daniel K. Turner · Director
  • Gilbert H. Kliman · Director
  • Jonathan T. Silverstein · Director
  • Robert J. More · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard L. Harrison, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 3, 2012. Read the notice at the SEC.

debt, optionsSEC
Aug 2012$5 MNo. 3$2 to $10 million

Glaukos Corp.: Raise no. 3, Aug 2012

Investors in this round

14 investors had bought by the notice of Aug 10, 2012: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Glaukos Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Olav B. Bergheim · Executive Officer, Director
  • Richard W. Harrison · Executive Officer
  • Thomas W. Burns · Executive Officer, Director
  • Daniel K. Turner · Director
  • Gilbert H. Kliman · Director
  • Jonathan T. Silverstein · Director
  • Robert J. More · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard L. Harrison, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 10, 2012. Read the notice at the SEC.

debt, optionsSEC
Jan 2011$30 MNo. 2$10 to $50 million

Glaukos Corp.: Raise no. 2, Jan 2011

Investors in this round

18 investors had bought by the notice of Feb 1, 2011: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Glaukos Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard L. Harrison · Executive Officer
  • Thomas W. Burns · Executive Officer, Director
  • Gilbert H. Kliman · Director
  • Jonathan T. Silverstein · Director
  • Manish N. Chapekar · Director
  • Olav B. Bergheim · Director
  • Robert J. More · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard L. Harrison, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 1, 2011. Read the notice at the SEC.

equitySEC
Sep 2010$6 MNo. 1$2 to $10 million

Glaukos Corp.: Raise no. 1, Sep 2010

Investors in this round

11 investors had bought by the notice of Sep 23, 2010: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 24 investors are named for Glaukos Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard L. Harrison · Executive Officer
  • Thomas W. Burns · Executive Officer, Director
  • Gilbert H. Kliman · Director
  • Jonathan T. Silverstein · Director
  • Manish N. Chapekar · Director
  • Olav B. Bergheim · Director
  • Robert J. More · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard L. Harrison, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 23, 2010. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Glaukos Corporation, its revenue in fiscal 2025 came from these product and service lines: Glaucoma $421.07 million (83%), Corneal Health $86.37 million (17%).

    Annual report (SEC XBRL) · Dec 2025

  • Glaukos Corp. chose not to state its revenue in its newest notice of a funding round (Jan 2013).

    SEC Form D · Jan 2013

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2013

Products and services#

No products or services of Glaukos Corp. are on record.

Investors#

24 named in official filings. Open an investor to see everything it has backed.

Investors in Glaukos Corp.
InvestorKindAmountRoundRoleSource
Chris M. CalcaterraPersonnot statednot statedHeld Series D preferred stock (Form 3, 2015)SEC Form 3
Domain Partners IV LPFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Domain Partners VIII, L.P.Fund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
DP IV Associates LPFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2015)SEC Form 3
DP VIII Associates, L.P.Fund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
FHM V, LLCOthernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
FHM V, LPFund or asset managernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Frazier Healthcare V, LPFund or asset managernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
InterWest Management Partners IX, LLCFund or asset managernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
InterWest Partners IX, LPFund or asset managernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Meritech Capital Affiliates III L.P.Fund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Meritech Capital Associates III L.L.C.Fund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Meritech Capital Partners III LPFund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Montreux Equity Management IV, LLCFund or asset managernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Montreux Equity Partners IV LPPrivate equitynot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Montreux IV Associates, LLCOthernot statednot statedHeld Series C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series D, E and F preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
OrbiMed Capital GP III LLCFund or asset managernot statednot statedHeld Series D, E and F preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Richard L. HarrisonPersonnot statednot statedHeld Series D preferred stock (Form 3, 2015)SEC Form 3
Versant Affiliates Fund I-A LPFund or asset managernot statednot statedHeld Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Versant Affiliates Fund I-B LPFund or asset managernot statednot statedHeld Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Versant Side Fund I LPFund or asset managernot statednot statedHeld Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Versant Venture Capital I LPVenture capitalnot statednot statedHeld Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Versant Ventures I LLCVenture capitalnot statednot statedHeld Series A, B, C, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 20 investors.

Largest shareholders today

Institutions holding Glaukos Corporation shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Glaukos Corp.
NameRoleNamed in
Olav B. BergheimExecutive officerJan 2013
Richard W. HarrisonExecutive officerJan 2013
Thomas W. BurnsExecutive officerJan 2013
Richard L. HarrisonExecutive officerFeb 2011
Daniel K. TurnerDirectorJan 2013
Gilbert H. KlimanDirectorJan 2013
Jonathan T. SilversteinDirectorJan 2013
Olav B. BergheimDirectorJan 2013
Paul S. MaderaDirectorJan 2013
Robert J. MoreDirectorJan 2013
Thomas W. BurnsDirectorJan 2013
William J. LinkDirectorJan 2013
Manish N. ChapekarDirectorFeb 2011

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.